• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉导管未闭的尿N末端脑钠肽前体水平及超声心动图参数

Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.

作者信息

Khan S S, Sithisarn T, Bada H S, Vranicar M, Westgate P M, Hanna M

机构信息

Division of Neonatology, Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, KY, USA.

Division of Pediatric Cardiology, Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, KY, USA.

出版信息

J Perinatol. 2017 Dec;37(12):1319-1324. doi: 10.1038/jp.2017.139. Epub 2017 Sep 14.

DOI:10.1038/jp.2017.139
PMID:28906496
Abstract

OBJECTIVE

Patent ductus arteriosus (PDA) is common in preterm infants and is associated with significant morbidities. B type natriuretic peptide (BNP) is synthesized in the ventricles secondary to volume overload and excreted as urinary N-terminal pro-brain natriuretic peptide (NT-proBNP).

STUDY DESIGN

We report an observational prospective study of 64 preterm infants with birth weight ⩽1000 g. Echocardiographic parameters were obtained from clinical echocardiograms performed in the first week of life. Urinary NT-proBNP/creatinine ratios (pg mg) were measured on the same day of the echocardiograms.

RESULTS

Infants with medium to large PDA (n=39) had significantly higher NT-proBNP/creatinine levels compared with infants with small PDA (n=10) (median (IQ range): 2333 (792-6166) vs 714 (271-1632) pg mg, P=0.01) and compared with infants with no PDA (n=15) (2333 (792-6166) vs 390 (134-1085) pg mg, P=0.0003). Urinary NT-proBNP/creatinine ratios were significantly lower post treatment if PDA closed (n=17), P=0.001 or if PDA became smaller after treatment (n=9), P=0.004. Urinary NT-proBNP/creatinine levels correlated with ductal diameter (P⩽0.0001), but not with LA/Ao ratio (P=0.69) or blood flow velocity through the ductus (P=0.06).

CONCLUSION

Our findings indicate that there is a positive correlation between ductal diameter and urinary NT-proBNP in preterm infants.

摘要

目的

动脉导管未闭(PDA)在早产儿中很常见,且与严重疾病相关。B型利钠肽(BNP)在容量超负荷继发于心室时合成,并作为尿N末端脑利钠肽原(NT-proBNP)排出。

研究设计

我们报告了一项对64例出生体重≤1000g的早产儿进行的观察性前瞻性研究。超声心动图参数取自出生后第一周进行的临床超声心动图检查。在超声心动图检查的同一天测量尿NT-proBNP/肌酐比值(pg/mg)。

结果

中至大型PDA患儿(n=39)的NT-proBNP/肌酐水平显著高于小型PDA患儿(n=10)(中位数(四分位间距):2333(792-6166) vs 714(271-1632)pg/mg,P=0.01),也高于无PDA患儿(n=15)(2333(792-6166) vs 390(134-1085)pg/mg,P=0.0003)。如果PDA闭合(n=17),治疗后尿NT-proBNP/肌酐比值显著降低,P=0.001;或者如果PDA在治疗后变小(n=9),P=0.004。尿NT-proBNP/肌酐水平与导管直径相关(P≤0.0001),但与左房/主动脉比值(P=0.69)或通过动脉导管的血流速度(P=0.06)无关。

结论

我们的研究结果表明,早产儿的导管直径与尿NT-proBNP之间存在正相关。

相似文献

1
Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.动脉导管未闭的尿N末端脑钠肽前体水平及超声心动图参数
J Perinatol. 2017 Dec;37(12):1319-1324. doi: 10.1038/jp.2017.139. Epub 2017 Sep 14.
2
Urinary NT-proBNP and ductal closure in preterm infants.尿 NT-proBNP 与早产儿动脉导管未闭。
J Perinatol. 2013 Mar;33(3):212-7. doi: 10.1038/jp.2012.86. Epub 2012 Jun 28.
3
[Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].[氨基末端脑钠肽前体作为早产儿症状性动脉导管未闭预测标志物的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Nov;17(11):1160-4.
4
N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.早产儿的N端脑钠肽前体与动脉导管未闭
J Perinatol. 2009 Feb;29(2):137-42. doi: 10.1038/jp.2008.185. Epub 2008 Nov 20.
5
Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.超声心动图血流模式与N末端脑钠肽前体之间的相关性分析用于动脉导管未闭的早期靶向治疗
J Matern Fetal Neonatal Med. 2014 Nov;27(17):1800-4. doi: 10.3109/14767058.2014.880879. Epub 2014 Feb 3.
6
N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.N 端前 B 型利钠肽:动脉导管未闭严重程度的一项指标。
Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F257-60. doi: 10.1136/adc.2007.120691. Epub 2008 Jan 24.
7
Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.连续测定N末端B型脑钠肽前体作为出生后第一周以上早产儿动脉导管未闭的预测指标。
Eur J Pediatr. 2014 Nov;173(11):1491-6. doi: 10.1007/s00431-014-2350-2. Epub 2014 Jun 5.
8
Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.动脉导管未闭的极早产儿血浆 C 端内皮素原和利钠肽前体 NT-proBNP 和 MR-proANP。
Neonatology. 2012;101(2):116-24. doi: 10.1159/000330411. Epub 2011 Sep 23.
9
Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants.非常低出生体重儿动脉导管未闭药物关闭后尿 NT-proBNP 升高。
Early Hum Dev. 2013 Mar;89(3):187-9. doi: 10.1016/j.earlhumdev.2012.09.020. Epub 2012 Oct 22.
10
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.

引用本文的文献

1
Utility of urinary NT-proBNP in congenital diaphragmatic hernia: a prospective pilot study.尿N末端B型利钠肽原在先天性膈疝中的应用:一项前瞻性初步研究。
Pediatr Res. 2025 Jun;97(7):2305-2311. doi: 10.1038/s41390-024-03600-x. Epub 2024 Oct 16.
2
NT-PROBNP as a screening tool for low-risk patent ductus arteriousus: a follow-up validation study.NT-PROBNP 作为低危动脉导管未闭的筛查工具:一项随访验证研究。
Eur J Pediatr. 2023 Dec;182(12):5465-5471. doi: 10.1007/s00431-023-05213-8. Epub 2023 Sep 29.
3
Urinary NT-proBNP: A Useful Biomarker for the Diagnosis of Respiratory Distress in the Neonatal Population.

本文引用的文献

1
Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.使用利钠肽诊断早产儿有临床意义的动脉导管未闭:系统评价。
Pediatrics. 2015 Feb;135(2):e510-25. doi: 10.1542/peds.2014-1995. Epub 2015 Jan 19.
2
Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants.非常低出生体重儿动脉导管未闭药物关闭后尿 NT-proBNP 升高。
Early Hum Dev. 2013 Mar;89(3):187-9. doi: 10.1016/j.earlhumdev.2012.09.020. Epub 2012 Oct 22.
3
Urinary NT-proBNP and ductal closure in preterm infants.
尿N末端脑钠肽前体:新生儿呼吸窘迫诊断的有用生物标志物。
Cureus. 2023 May 15;15(5):e39019. doi: 10.7759/cureus.39019. eCollection 2023 May.
4
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
5
An Update on Patent Ductus Arteriosus and What is Coming Next.动脉导管未闭的最新情况及后续发展
Turk Arch Pediatr. 2022 Mar;57(2):118-131. doi: 10.5152/TurkArchPediatr.2022.21361.
6
Serum N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Critical Pulmonary Stenosis in Neonates.血清N末端B型利钠肽原作为新生儿重度肺动脉狭窄的生物标志物
Front Pediatr. 2022 Jan 5;9:788715. doi: 10.3389/fped.2021.788715. eCollection 2021.
7
Application of block matching method-based Echocardiography combined with serum NT-PROBNP level detection in the early prediction of PDA in premature infants.基于块匹配法的超声心动图联合血清NT - PROBNP水平检测在早产儿动脉导管未闭早期预测中的应用
Pak J Med Sci. 2021;37(6):1657-1661. doi: 10.12669/pjms.37.6-WIT.4864.
8
Urinary N-terminal pro-brain natriuretic peptide: prognostic value in patients with acute chest pain.尿 N 末端脑利钠肽前体:急性胸痛患者的预后价值。
ESC Heart Fail. 2021 Jun;8(3):2293-2305. doi: 10.1002/ehf2.13332. Epub 2021 Apr 6.
9
Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates.极早产儿中与血流动力学显著的动脉导管未闭相关的生理改变的客观评估
Front Pediatr. 2021 Feb 25;9:648584. doi: 10.3389/fped.2021.648584. eCollection 2021.
10
Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data.动脉导管未闭早期尿液代谢组学可预测预后:初步数据
Front Pediatr. 2020 Dec 21;8:613749. doi: 10.3389/fped.2020.613749. eCollection 2020.
尿 NT-proBNP 与早产儿动脉导管未闭。
J Perinatol. 2013 Mar;33(3):212-7. doi: 10.1038/jp.2012.86. Epub 2012 Jun 28.
4
Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants.尿 N 末端 proB 型利钠肽、中性粒细胞明胶酶相关脂质运载蛋白和心脏型脂肪酸结合蛋白可能预测极低出生体重儿动脉导管未闭的血流动力学相关性。
Neonatology. 2012;101(4):260-6. doi: 10.1159/000334826. Epub 2012 Jan 4.
5
Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.动脉导管未闭的极早产儿血浆 C 端内皮素原和利钠肽前体 NT-proBNP 和 MR-proANP。
Neonatology. 2012;101(2):116-24. doi: 10.1159/000330411. Epub 2011 Sep 23.
6
Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity.尿 N 端 B 型利钠肽预测严重早产儿视网膜病变。
Pediatrics. 2011 Sep;128(3):e545-9. doi: 10.1542/peds.2011-0603. Epub 2011 Aug 8.
7
B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.B 型利钠肽可预测对动脉导管未闭早产儿吲哚美辛治疗的反应。
J Pediatr. 2010 Jul;157(1):79-84. doi: 10.1016/j.jpeds.2009.12.045. Epub 2010 Mar 15.
8
N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction.用于心力衰竭和左心室功能障碍生化检测的新鲜尿液中的 N-末端脑利钠肽前体。
Eur J Heart Fail. 2010 Apr;12(4):331-7. doi: 10.1093/eurjhf/hfq016. Epub 2010 Feb 25.
9
Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.慢性心力衰竭患者尿N末端脑钠肽前体排泄情况
Circulation. 2009 Jul 7;120(1):35-41. doi: 10.1161/CIRCULATIONAHA.108.824581. Epub 2009 Jun 22.
10
Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.早期N末端脑钠肽前体测量可预测早产儿临床上显著的动脉导管未闭。
Acta Paediatr. 2009 Aug;98(8):1254-9. doi: 10.1111/j.1651-2227.2009.01315.x. Epub 2009 Apr 30.